ArticleRSC advances2026
Mangiferin and oleocanthal in the modulation of oxidative stress in monocytes and macrophages.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress and inflammation are tightly interconnected processes that contribute to the pathogenesis of numerous chronic diseases. In this study, we investigated the anti-inflammatory and antioxidant potential of two plant-derived bioactive compounds, mangiferin and oleocanthal, in human monocytic U-937 cells differentiated into macrophage-like cells. Cells were stimulated with phorbol 12-myristate 13-acetate (PMA), with or without lipopolysaccharide (LPS), to induce oxidative and inflammatory responses. The effects of mangiferin and oleocanthal (5 µM) were evaluated using cell viability assays, confocal microscopy, western blot analysis of tumor necrosis factor-α (TNF-α), 5-lipoxygenase (5-LOX) and electron paramagnetic resonance (EPR) spin-trapping spectroscopy for reactive oxygen species (ROS) detection. Both compounds were well tolerated and did not compromise membrane integrity or cell viability. Mangiferin and oleocanthal significantly reduced TNF-α expression and increased IL-4 expression in PMA and PMA/LPS-stimulated cells. While 5-LOX expression remained unchanged under PMA-induced differentiation alone, both compounds decreased 5-LOX levels under LPS-induced inflammatory conditions. EPR analysis confirmed suppression of ROS-derived radical formation following treatment with the bioactive compounds. Our results demonstrate that mangiferin and oleocanthal modulate oxidative stress and inflammatory signaling in macrophage-like cells by targeting TNF-α, 5-LOX, and ROS generation. These findings highlight their potential as natural therapeutic candidates for controlling inflammation-associated disorders.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.